J+
JOHNSON + JOHNSON
JNJ· Health Care· PharmaceuticalsS&P 500
Close · 16/09/2026
267.28
1D
+0.03%52-week range
173.33 – 281.07
Volume
48,87,300.00
Price history
JNJ
17/08/2026 to 16/09/2026
O 266.81 H 268.65 L 266.30
1W+0.07%
1M+1.87%
3M+13.65%
6M+12.25%
1Y+50.67%
3Y+64.32%
5Y+55.49%
MAX+56.84%
Fundamentals
as of 16/09/2026- Market cap
- $644.12B
- Shares out
- 2.41B
- P/E (trailing)
- 30.62
- P/E (forward)
- 21.33
- EPS (trailing)
- 8.73
- Dividend yield
- 1.98%
- Beta
- 0.24
- Profit margin
- 21.48%
- P/B
- 7.58
- Return on equity
- 24.76%
SEC financial statements
68 quarterly and 19 annual periods through 28/06/2026.
Details
- Ticker
- JNJ
- Index
- SP500
- Sector
- Health Care
- Industry
- Pharmaceuticals
- HQ
- -
Last close 16/09/2026.
Tracked by Congress
51 filers · 4 on watchlist · 93 buys · 70 sells · ?: 27 · R: 68 · D: 68
- 27/08/2026Thomas H. KeanSell+Johnson & Johnson Common Stock$1,001–$15,000
- 20/08/2026John BoozmanWSell+Johnson & Johnson Common Stock$1,001–$15,000
- 30/07/2026Richard Dean Dr McCormickSellJohnson & Johnson Common Stock$1,001–$15,000
- 29/10/2024Thomas H TubervilleWSellJohnson & Johnson Common Stock$15,001–$50,000
- 29/10/2024Thomas H TubervilleWSellJohnson & Johnson Common Stock$15,001–$50,000
- 30/03/2026Alan ArmstrongBuyJohnson & Johnson Common Stock$1,001–$15,000
- 27/03/2026Alan ArmstrongBuyJohnson & Johnson Common Stock$15,001–$50,000
- 29/06/2026Thomas H. KeanSell+Johnson & Johnson Common Stock$1,001–$15,000